Publications
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
August 12, 2021
Background
Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection.